Aman Kapadia - Jun 25, 2021 Form 4 Insider Report for Lionheart Acquisition Corp. II (LIFW)

Role
Director
Signature
/s/ Aman Kapadia
Stock symbol
LIFW
Transactions as of
Jun 25, 2021
Transactions value $
-$1,800,000
Form type
4
Date filed
7/7/2021, 09:40 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFW Class A Common Stock Sale -$1.8M -180K -100% $10.00* 0 Jun 25, 2021 By Akaris Global Partners LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFW Class B Common Stock Sale -540K -100% 0 Jun 25, 2021 Class A Common Stock 540K By Akaris Global Partners LP F1, F2
transaction LIFW Warrants to purchase Class A Common Stock Sale -90K -100% 0 Jun 25, 2021 Class A Common Stock 90K $11.50 By Akaris Global Partners LP F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Aman Kapadia is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with Mr. Aman Kapadia's resignation as a director of the issuer, Mr. Kapadia disposed of the issuer's private placement units and Class B Common Stock held by vehicles and accounts managed by Akaris Global Partners LP, an entity over which Mr. Kapadia has voting and dispositive power. Each private placement unit consists of one share of Class A Common Stock and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A Common Stock at a price of $11.50 per share, subject to certain adjustments.
F2 As described in the issuer's registration statement on Form S-1 (File No. 333-240130) (the "Registration Statement"), the shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date.
F3 The warrants become exercisable on the later of (i) 30 days after the completion of the issuer's initial business combination and (ii) August 18, 2021.
F4 The warrants expire five years after the completion of the issuer's initial business combination or earlier upon redemption or liquidation, as described in the Registration Statement.